OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out MRK/  DE000MB5L8U0  /

Stuttgart
2024-05-15  5:52:34 PM Chg.+0.72 Bid10:00:36 PM Ask10:00:36 PM Underlying Strike price Expiration date Option type
3.88EUR +22.78% -
Bid Size: -		 -
Ask Size: -		 MERCK KGAA O.N. 126.1956 - 2078-12-31 Call
GlobeNewswire 12:00 AM Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-15 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 05-15 Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VIS...
GlobeNewswire 05-15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 05-15 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-15 PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
TeleTrader 05-15 Europe opens higher with data in limelight
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
TeleTrader 02-02 Merck Group to expand investment in South Korea
TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B
TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices
GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck
GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B
TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 2023-10-17 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
GlobeNewswire 2023-09-28 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
TeleTrader 2023-08-29 US gov't reveals drugs subject to Medicare price debate
TeleTrader 2023-08-01 Merck posts Q2 sales of $15B, rising 3%